Kyrgyzstan delegation discusses centralized drug procurement with Kazakhstan's 'SK-Pharmaсiya'

A delegation from Kyrgyzstan's state enterprise "Kyrgyzpharmatsiya" has undertaken a working visit to Almaty, Kazakhstan, to explore avenues for enhancing centralized drug procurement and supply systems. The Kyrgyz representatives held discussions with "SK-Pharmaсiya," Kazakhstan's designated sole distributor for medicines and medical devices.

The primary objective of the meeting was to identify promising areas for bilateral cooperation aimed at refining the centralized drug supply system. Key topics on the agenda included the development of centralized and consolidated procurement mechanisms for medicines and medical products, the exchange of practical experience in organizing state procurement and drug provision, and fostering collaboration with domestic and international manufacturers.

Furthermore, the discussions focused on improving logistical processes, ensuring supply chain stability, and studying Kazakhstan's successful strategies in centralized drug supply. The Kyrgyz delegation also toured "SK-Pharmaсiya's" modern logistics hub, which is certified under the international Good Distribution Practice (GDP) standard.

During their tour, the Kyrgyz representatives examined the organization of warehouse logistics, storage requirements for medicines and medical devices, temperature monitoring systems, and handling procedures for temperature-sensitive products. They also studied the processes for receiving, assembling, and dispatching goods, as well as mechanisms for ensuring product quality, traceability, and safety throughout the supply chain.

The experience gained from this visit is intended to inform "Kyrgyzpharmatsiya's" own projects for developing modern logistics infrastructure, including the establishment of its own warehouse complex that meets international GDP standards. "Kyrgyzpharmatsiya" was created in March 2023 to improve medicine accessibility in state hospitals, though patients have reported issues. The enterprise currently centrally procures 191 types of medicines as per a Ministry of Health order.